Search research articles
Contact Us
Filters
Showing results (71-80 of 208) with videos related to
Page
of 21
Sort By:
Blood
|
February 15, 2003
Rituximab in lymphocyte-predominant Hodgkin disease: results of a phase 2 trial
Bradley C Ekstrand, Jennifer B Lucas, Steven M Horwitz, et al.
Blood
|
March 22, 2014
Objective responses in relapsed T-cell lymphomas with single-agent brentuximab vedotin
Steven M Horwitz, Ranjana H Advani, Nancy L Bartlett, et al.
Blood Advances
|
April 9, 2024
Somatic mutations in FAS pathway increase hemophagocytic lymphohistiocytosis risk in patients with T- and/or NK-cell lymphoma
Ying Liu, Rohan Sardana, David Nemirovsky, et al.
Cancer Medicine
|
October 1, 2019
Incidence of benign and malignant peri-implant fluid collections and masses on magnetic resonance imaging in women with silicone implants
Elizabeth J Sutton, Brittany Z Dashevsky, Elizabeth J Watson, et al.
British Journal of Haematology
|
August 24, 2005
Primary mediastinal large B-cell lymphoma: optimal therapy and prognostic factor analysis in 141 consecutive patients treated at Memorial Sloan Kettering from 1980 to 1999
Paul A Hamlin, Carol S Portlock, David J Straus, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
September 10, 2025
Skin Response to Mogamulizumab in Patients With Mycosis Fungoides and Sezary Syndrome: A Retrospective, Real World Cohort
Rachel E Christensen, Robert Stuver, Stephen Dusza, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
September 17, 2013
A retrospective analysis of peripheral T-cell lymphoma treated with the intention to transplant in the first remission
Neha Mehta, Jocelyn C Maragulia, Allison Moskowitz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 23, 2007
Phase I/II study of an anti-CD30 monoclonal antibody (MDX-060) in Hodgkin's lymphoma and anaplastic large-cell lymphoma
Stephen M Ansell, Steven M Horwitz, Andreas Engert, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
May 1, 2012
Pralatrexate is an effective treatment for relapsed or refractory transformed mycosis fungoides: a subgroup efficacy analysis from the PROPEL study
Francine Foss, Steven M Horwitz, Bertrand Coiffier, et al.
Haematologica
|
March 19, 2026
Non-JAK-family gene fusions in cutaneous T-cell lymphoma highlights genetic diversity and potential therapeutic targets
Robert Stuver, Haiming Tang, Ahmet Dogan, et al.
Page
of 21
Search research articles
Search
Showing results (71-80 of 208) with videos related to
Sort By:
Page
of 21
Blood
|
February 15, 2003
Rituximab in lymphocyte-predominant Hodgkin disease: results of a phase 2 trial
Bradley C Ekstrand, Jennifer B Lucas, Steven M Horwitz, et al.
Blood
|
March 22, 2014
Objective responses in relapsed T-cell lymphomas with single-agent brentuximab vedotin
Steven M Horwitz, Ranjana H Advani, Nancy L Bartlett, et al.
Blood Advances
|
April 9, 2024
Somatic mutations in FAS pathway increase hemophagocytic lymphohistiocytosis risk in patients with T- and/or NK-cell lymphoma
Ying Liu, Rohan Sardana, David Nemirovsky, et al.
Cancer Medicine
|
October 1, 2019
Incidence of benign and malignant peri-implant fluid collections and masses on magnetic resonance imaging in women with silicone implants
Elizabeth J Sutton, Brittany Z Dashevsky, Elizabeth J Watson, et al.
British Journal of Haematology
|
August 24, 2005
Primary mediastinal large B-cell lymphoma: optimal therapy and prognostic factor analysis in 141 consecutive patients treated at Memorial Sloan Kettering from 1980 to 1999
Paul A Hamlin, Carol S Portlock, David J Straus, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
September 10, 2025
Skin Response to Mogamulizumab in Patients With Mycosis Fungoides and Sezary Syndrome: A Retrospective, Real World Cohort
Rachel E Christensen, Robert Stuver, Stephen Dusza, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
September 17, 2013
A retrospective analysis of peripheral T-cell lymphoma treated with the intention to transplant in the first remission
Neha Mehta, Jocelyn C Maragulia, Allison Moskowitz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 23, 2007
Phase I/II study of an anti-CD30 monoclonal antibody (MDX-060) in Hodgkin's lymphoma and anaplastic large-cell lymphoma
Stephen M Ansell, Steven M Horwitz, Andreas Engert, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
May 1, 2012
Pralatrexate is an effective treatment for relapsed or refractory transformed mycosis fungoides: a subgroup efficacy analysis from the PROPEL study
Francine Foss, Steven M Horwitz, Bertrand Coiffier, et al.
Haematologica
|
March 19, 2026
Non-JAK-family gene fusions in cutaneous T-cell lymphoma highlights genetic diversity and potential therapeutic targets
Robert Stuver, Haiming Tang, Ahmet Dogan, et al.
Page
of 21